UNIOVI-PEDIATRIA
OVIPED
ISAAC
PASCUAL CALLEJA
Profesor Asociado en CC. Salud - LOSU
Publicaciones en las que colabora con ISAAC PASCUAL CALLEJA (14)
2024
-
PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal
International Journal of Cardiology, Vol. 413
-
Retrospective variant reclassification and resequencing in hypertrophic cardiomyopathy: a reference unit centre experience
European Journal of Preventive Cardiology, Vol. 31, Núm. 6, pp. e38-e41
-
Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing
International Journal of Cardiology, Vol. 408
2023
-
Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence
Journal of Clinical Medicine, Vol. 12, Núm. 6
-
Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
2021
-
The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568
2020
-
Characterization of left ventricular non-compaction cardiomyopathy
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-16
-
Clinical implications and gender differences of kcnq1 p.Gly168arg pathogenic variant in long qt syndrome
Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-12
-
Familial hypercholesterolemia in premature acute coronary syndrome. Insights from cholestemi registry
Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-12
-
IL17RA in early-onset coronary artery disease: Total leukocyte transcript analysis and promoter polymorphism (rs4819554) association
Cytokine, Vol. 136
2019
-
Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease
Immunology Letters, Vol. 208, pp. 39-43
-
Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant
Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 138-144